Neutralizing Activity of Broadly Neutralizing Anti-HIV-1 Antibodies against Clade B Clinical Isolates Produced in Peripheral Blood Mononuclear Cells

Recently discovered broadly neutralizing antibodies (bNAbs) against HIV-1 demonstrate extensive breadth and potency against diverse HIV-1 strains and represent a promising approach for the treatment and prevention of HIV-1 infection. The breadth and potency of these antibodies have primarily been ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Yehuda Z., Lorenzi, Julio C. C., Seaman, Michael S., Nogueira, Lilian, Schoofs, Till, Krassnig, Lisa, Butler, Allison, Millard, Katrina, Fitzsimons, Tomas, Daniell, Xiaoju, Dizon, Juan P., Shimeliovich, Irina, Montefiori, David C., Caskey, Marina, Nussenzweig, Michel C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2018
Materias:
Vaccines and Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809738/
https://www.ncbi.nlm.nih.gov/pubmed/29237833
http://dx.doi.org/10.1128/JVI.01883-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809738/
https://www.ncbi.nlm.nih.gov/pubmed/29237833
http://dx.doi.org/10.1128/JVI.01883-17

Ejemplares similares